174 related articles for article (PubMed ID: 1386404)
41. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF
Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482
[TBL] [Abstract][Full Text] [Related]
42. Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy.
Ganotakis ES; Mandalaki K; Tampakaki M; Malliaraki N; Mandalakis E; Vrentzos G; Melissas J; Castanas E
Angiology; 2003; 54(5):569-76. PubMed ID: 14565632
[TBL] [Abstract][Full Text] [Related]
43. Plasma lipoprotein(a) concentration in familial hypercholesterolemic patients without coronary artery disease.
Ghiselli G; Gaddi A; Barozzi G; Ciarrocchi A; Descovich G
Metabolism; 1992 Aug; 41(8):833-8. PubMed ID: 1386403
[TBL] [Abstract][Full Text] [Related]
44. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature.
Danese MD; Ladenson PW; Meinert CL; Powe NR
J Clin Endocrinol Metab; 2000 Sep; 85(9):2993-3001. PubMed ID: 10999775
[TBL] [Abstract][Full Text] [Related]
45. Concentrations of the atherogenic Lp(a) are elevated in FH.
Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
[TBL] [Abstract][Full Text] [Related]
46. Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.
Vessby B; Kostner G; Lithell H; Thomis J
Atherosclerosis; 1982 Jul; 44(1):61-71. PubMed ID: 6214264
[TBL] [Abstract][Full Text] [Related]
47. Oxidation of lipoprotein(a) and low density lipoprotein containing density gradient ultracentrifugation fractions.
Kleinveld HA; Duif PF; Pekelharing HL; van Rijn HJ
Biochim Biophys Acta; 1996 Sep; 1303(1):15-21. PubMed ID: 8816848
[TBL] [Abstract][Full Text] [Related]
48. Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.
Li L; Weng W; Harrison EH; Fisher EA
Metabolism; 2008 Oct; 57(10):1361-8. PubMed ID: 18803939
[TBL] [Abstract][Full Text] [Related]
49. Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in beta-thalassemia.
Maioli M; Vigna GB; Tonolo G; Brizzi P; Ciccarese M; Donegà P; Maioli M; Fellin R
Atherosclerosis; 1997 May; 131(1):127-33. PubMed ID: 9180253
[TBL] [Abstract][Full Text] [Related]
50. Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects.
Knight BL; Perombelon YF; Soutar AK; Wade DP; Seed M
Atherosclerosis; 1991 Apr; 87(2-3):227-37. PubMed ID: 1830206
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice.
Hofmann SL; Eaton DL; Brown MS; McConathy WJ; Goldstein JL; Hammer RE
J Clin Invest; 1990 May; 85(5):1542-7. PubMed ID: 2139667
[TBL] [Abstract][Full Text] [Related]
52. Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B.
Menys VC; Liu Y; Mackness MI; Caslake MJ; Kwok S; Durrington PN
Clin Chim Acta; 2003 Aug; 334(1-2):95-106. PubMed ID: 12867279
[TBL] [Abstract][Full Text] [Related]
53. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
Ginsberg HN; Le NA; Gibson JC
J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
[TBL] [Abstract][Full Text] [Related]
54. The effects of thyroid status on serum apolipoprotein A-I-containing lipoprotein particles.
Ozata M; Yildirimkaya M; Yilmaz K; Kutluay T; Corakci A; Beyhan Z; Gundogan MA
Horm Metab Res; 1998 Apr; 30(4):217-21. PubMed ID: 9623637
[TBL] [Abstract][Full Text] [Related]
55. LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients.
Kronenberg F; Trenkwalder E; Sturm W; Kathrein H; König P; Neyer U; Gröchenig E; Utermann G; Dieplinger H
Clin Genet; 1997 Nov; 52(5):377-86. PubMed ID: 9520130
[TBL] [Abstract][Full Text] [Related]
56. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism.
Duntas LH; Mantzou E; Koutras DA
Thyroid; 2002 Nov; 12(11):1003-7. PubMed ID: 12490078
[TBL] [Abstract][Full Text] [Related]
57. The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans.
Demant T; Seeberg K; Bedynek A; Seidel D
Atherosclerosis; 2001 Aug; 157(2):325-39. PubMed ID: 11472732
[TBL] [Abstract][Full Text] [Related]
58. Relationship between insulin-like growth factor-I and low-density lipoprotein cholesterol levels in primary hypothyroidism in women.
Hoogerbrugge-vd Linden N; Jansen H; Hülsmann WC; Birkenhäger JC
J Endocrinol; 1989 Nov; 123(2):341-5. PubMed ID: 2607248
[TBL] [Abstract][Full Text] [Related]
59. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
[TBL] [Abstract][Full Text] [Related]
60. Effect of low-density lipoprotein buoyant density and cholesterol content on the formation of lipoprotein(a) particles.
Becker L; Gabel BR; Spencer CA; Marcovina SM; Koschinsky ML
Clin Exp Med; 2001 Jun; 1(2):121-5. PubMed ID: 11699729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
